- Q1 2024 SpringWorks Therapeutics Inc Earnings Call TranscriptMay 02, 2024$43.35 (-7.45%)Earnings
- SpringWorks Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- SpringWorks Therapeutics to Discuss The ReNeu Topline Data TranscriptNov 16, 2023
- SpringWorks Therapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- SpringWorks Therapeutics Inc at TD Cowen Oncology Innovation Summit (Virtual) TranscriptMay 31, 2023
- SpringWorks Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- SpringWorks Therapeutics Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- SpringWorks Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- SpringWorks Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- SpringWorks Therapeutics Inc at H.C. Wainwright Precision Oncology Conference (Virtual) TranscriptNov 14, 2022
- SpringWorks Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- SpringWorks Therapeutics Inc R&D Day (Virtual) TranscriptJun 10, 2022
- SpringWorks Therapeutics Inc To Discuss The DeFi Trial Data Call TranscriptMay 24, 2022
- SpringWorks Therapeutics Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 10, 2022
- SpringWorks Therapeutics Inc and the ReNeu Trial for NF1-Related Plexiform Neurofibromas TranscriptJul 15, 2021
- SpringWorks Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- SpringWorks Therapeutics to Discuss the Reneu Trial Data and Program Update Call TranscriptFeb 25, 2021
- SpringWorks Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- SpringWorks Therapeutics Inc Clinical Trials TranscriptOct 13, 2020
Q1 2024 SpringWorks Therapeutics Inc Earnings Call Transcript
Good morning. My name is Towanda, and I will be your conference operator today. At this time, I would like to welcome everyone. The SpringWorks Therapeutics first quarter 2024 earnings conference call. (Operator Instructions)
Thank you. I would now like to hand the conference over to Samantha Sandler, Senior Director of Investor Relations at SpringWorks Therapeutics Summit. You may now begin the conference.
Thank you and good morning, everyone. Welcome to SpringWorks Therapeutics first quarter 2024 earnings conference call. This morning, we issued a press release which outlines the topics we plan to discuss today you can access the press release as well as the slides that we'll be reviewing today by going to the Investors and Media section of our website at www.springworkstx.com.
Joining me today are Saqib Islam, Chief Executive Officer; Bhavesh Ashar, Chief Commercial Officer; Dr. Jim
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)